| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Aug 7, 2025 | NCG Micro Cap Growth Strategy | 12.7% | 0.6% | OWLT, SIBN, SITM, SPRY, STRL, TITN, TMDX | growth, healthcare, infrastructure, Micro Cap, small cap, technology, Trade Policy, valuation | Strong forces driving increased infrastructure spending in the US have been gaining momentum for the past couple years and remain intact. The new administration is working to accelerate this trend and NCG is finding companies which are direct beneficiaries. | View | |
| 2025 Q2 | Aug 7, 2025 | NCG Small Cap Growth Strategy | 12.7% | -1.9% | AAON, AGYS, ALHC, AVPT, CDNA, CELH, CRS, CWK, ELF, GDYN, GWRE, HXL, INOD, MTSI, RXST, SAIA, SPRY, STRL, TMDX, TTAN | growth, healthcare, infrastructure, rates, small cap, technology, Trade Policy | Small cap growth stocks participated in the recent market rally, but further opportunity exists. The rolling 10-year annualized return by small vs large stands at -7.3% and is the worst ever going back to 1926, and the valuation of the small cap sector relative to large caps is in the 5th percentile historically. | View | |
| 2025 Q2 | Aug 7, 2025 | NCG SMID Cap Growth Strategy | 13.5% | -2.5% | ALHC, CDNA, CELH, CRS, ELF, GDYN, SAIA, SPRY, STRL, TMDX, TTAN, VRT | growth, healthcare, infrastructure, rates, small caps, technology, Trade Policy | Strong forces driving increased infrastructure spending in the US have been gaining momentum for the past couple years and remain intact. The new administration is working to accelerate this trend and NCG is finding companies which are direct beneficiaries. | View | |
| 2024 Q2 | Jul 11, 2024 | Headwaters Capital Management, LLC | 8.8% | 21.4% | AMAT, ANSS, ASML, CDNS, INSP, INTC, KLAC, KLIC, NVDA, PDFS, SNPS, TMDX | AI, Medical Devices, mid cap, semiconductors, small caps, technology, value | The manager discusses semiconductor manufacturing complexity and the need for advanced yield optimization software. PDF Solutions is positioned to benefit from increasing complexity at advanced nodes and the emergence of new foundries investing at the leading edge. | View | |
| 2025 Q2 | Jul 10, 2025 | Headwaters Capital Management, LLC | 7.3% | -2.6% | COIN, DHR, GMED, HOOD, MSTR, NVDA, PLTR, TECH, TMDX, TMO | AI, Biotechnology, mid cap, Risk Appetite, small caps, valuation | AI enthusiasm is driving large cap outperformance and creating narrow market breadth concentrated in AI beneficiaries. The manager believes AI is real with lasting benefits but excitement around valuations is reaching extremes similar to 1999. History suggests the AI cycle will eventually reach over-investment and excess capacity. | TECH TECH |
View |
| 2026 Q1 | Apr 22, 2026 | Baird Small/Mid Cap Growth Equity Fund | -4.8% | -4.8% | ADMA, AFRM, ALGN, BMI, BRBR, BSX, BURL, CASY, CRBG, CROX, DHR, DXCM, ELF, EQH, EXAS, FIX, FN, FND, FOUR, FTAI, HLI, HUBB, ILMN, INSP, JBL, KNSL, KTOS, LFUS, LII, MASI, MTDR, NSA, PEN, PODD, PSA, RGEN, SOFI, TMDX, TTAN, TWST, VSCO, WWD, XPO | AI, defense, growth, healthcare, industrials, semiconductors, small caps, technology | View | ||
| 2024 Q1 | Apr 22, 2024 | Rodrigo Benedetti | 0.0% | 0.0% | AM.PA, APP, CHG.L, CLS, HO.PA, KNF, MRVI, ONT.L, OXB.L, PFE, PSTG, SMR.AX, TEP.PA, TMDX | Biotech, defense, Europe, growth, small caps, value | European defense companies trade at reasonable multiples with potential tailwinds from awakening EU defense budgets. Dassault Aviation produces the Rafale fighter, the only Fifth Generation aircraft not made by Lockheed Martin or Russians, with growing order book and no competing aircraft expected soon. | AM.PA |
View |
| 2023 Q1 | Mar 31, 2023 | Driehaus Micro Cap Growth Strategy | 2.0% | 2.0% | AGYS, ELF, PI, TMDX, UBS, XENE | Banking Crisis, Fed policy, growth, healthcare, inflation, Micro Cap, Recession, technology | Regional bank failures including Silicon Valley Bank and Signature Bank created a banking crisis in March. The crisis was driven by concentrated deposit bases, uninsured deposits, and forced treasury sales at losses rather than credit quality issues. Emergency Fed measures including deposit guarantees and the Bank Term Funding Program helped restore stability. | View | |
| 2024 Q4 | Mar 12, 2025 | Invesco Discovery Fund | 1.2% | 22.6% | ALAB, AMZN, CLH, CLS, CRS, CYBR, DUOL, EHC, EVR, FIX, INTA, MOD, NVDA, ONTO, PEGA, PI, QTWO, STEP, TMDX, WING | AI, Cloud, growth, semiconductors, small cap, software, technology | Technology driven innovation has continued to disrupt large portions of the global economy, providing substantial opportunity through investment in premier growth compounders. The fund added Pegasystems which has increasingly integrated artificial intelligence functionality into its products, with newest AI releases representing more than 25% of its bookings. Intapp offers cloud-based and AI-powered software solutions for the financial services industry. | INTA CVLT PEGA |
View |
| 2024 Q4 | Feb 10, 2025 | Meridian Growth Fund | -0.8% | 6.3% | ALIT, CARG, CHDN, DOCS, EEFT, GNRC, OKTA, RBA, RELY, ST, STE, TMDX, TRMB, ZD | growth, healthcare, industrials, Quality, small caps, technology | The portfolio's largest allocation with historically attractive valuations below long-term averages. Utilization has recovered above pre-pandemic levels and investor interest in biotechnology is showing signs of revival. | CARG RELY DOCS STE ST TMDX |
View |
| 2024 Q4 | Feb 10, 2025 | Meridian Small Cap Growth Fund | 2.8% | 11.7% | AGS, ALIT, ANGI, BYRN, CARG, CCSI, MIR, RBA, SMAR, STNE, TMDX, TPB, WAY | growth, healthcare, nuclear, Quality, risk management, small caps, technology | Mirion Technologies operates in industries with strong secular trends tied to rising demand for nuclear power, including AI-related data center energy needs. The company provides critical technologies for the nuclear power sector with recurring revenues. | ANGI SRI TMDX BYRN TPB MRAD |
View |
| 2024 Q4 | Dec 31, 2024 | Minot Light Capital Partners | 5.2% | - | BYON, CFR.SW, DERM, MYTE, REAL, TDUP, TMDX | Dermatology, E-Commerce, growth, Luxury, Microcap, small caps, Specialty Pharma, value | The fund's largest holding MyTheresa operates in the high-end luxury fashion space and recently acquired YOOX NET-A-PORTER from Richemont. The transaction creates substantial synergies and establishes MyTheresa as a leading curated digital platform for luxury fashion. Management expects the combined legacy MYTE and Mr. Porter brands to generate around $2.2 billion in revenues in 2025. | DERM MYTE |
View |
| 2024 Q4 | Dec 31, 2024 | Wasatch Small Cap Growth Strategy | 1.7% | 15.2% | BOOT, BRBR, PACS, PCTY, ROAD, TMDX | consumer, financials, growth, healthcare, infrastructure, SaaS, small cap, technology | U.S. small-cap stocks gained after the November election on expectations of less regulation, tax cuts and stronger economic growth. The managers believe business conditions are generally favorable for smaller companies, though they note some pockets of consumer spending weakness. | TMDX ROAD PCTY BRBR |
View |
| 2023 Q4 | Dec 31, 2023 | NCG Small Cap Growth Strategy | 4.8% | 14.8% | BRZE, CSTL, CWAN, DAVA, FLYW, GWRE, KNSL, LGIH, MEDP, NTRA, SILK, TMDX, TNDM, VRRM | Biotechnology, Fed Pivot, growth, healthcare, market breadth, small caps | Small cap stocks underperformed large caps heading into the fourth quarter, with the Russell Microcap Growth Index down about 5% through Q3. However, market breadth broadened in November and December following the Fed pivot, with the Russell Microcap Growth Index returning 13.68% versus 4.42% for large caps. The rally was primarily led by low quality stocks and sectors most impacted by the Fed's restrictive stance. | CSTL TNDM ASIC|CWAN|INSP|KRMN|KTOS|MAC|MEG|RH|WYNN NTRA ARGX BB|DAVA|DDOG|GLOB|ILMN|LOAR|MELI|NET|NU|NVDA|TSM ACGL|APH|COO|CSGP|DKNG|GWRE|IDXX|IOT|IT|LPLA|MSCI|MTD|PCOR|ROP|TECH|VRSK BRZE MEDP |
View |
| 2023 Q4 | Dec 31, 2023 | NCG SMID Cap Growth Strategy | 4.8% | 15.5% | BRZE, CSTL, CWAN, DAVA, DXCM, FLYW, GWRE, KNSL, LGIH, MEDP, NTRA, SILD, TMDX, TNDM, VRRM, VRT | Biotech, growth, healthcare, Medical Devices, small caps, technology | Healthcare holdings drove much of the underperformance across strategies due to investor perception that GLP-1 drugs will reduce medical interventions. Many healthcare companies began recovering in Q4 and the firm believes in long-term growth fundamentals. The firm continues direct research to inform investment decisions in this space. | DXCM MELI|NFLX|ORCL|TCOM|VRTX|YUMC CSTL TNDM ASIC|CWAN|INSP|KRMN|KTOS|MAC|MEG|RH|WYNN NTRA ARGX BB|DAVA|DDOG|GLOB|ILMN|LOAR|MELI|NET|NU|NVDA|TSM ACGL|APH|COO|CSGP|DKNG|GWRE|IDXX|IOT|IT|LPLA|MSCI|MTD|PCOR|ROP|TECH|VRSK BRZE MEDP |
View |
| 2024 Q3 | Oct 7, 2024 | Rodrigo Benedetti | - | - | ABT, APP, ARKK, ASTS, COOP, EW, HIFS, KRE, LUMN, MBIN, MDT, MEDP, PFBC, TMDX | Europe, financials, Medical Devices, Shorts, Tankers, trading, volatility | Manager sees opportunities in tankers due to seasonal weakness ending and Middle East conflict escalation. Expects enforcement of dark fleet sanctions to benefit compliant fleet carrying offsetting output from Saudi Arabia and others, tightening ship availability. However, notes growing orderbook and higher valuations make tankers difficult as long-term holds. | EW |
View |
| 2025 Q3 | Oct 29, 2025 | Polen Capital – U.S. Small Company Growth | 21.1% | 27.1% | BE, BLDE, CRS, JOBY, ODD, ORCL, POWL, TMDX | aerospace, AI, Data centers, Electrification, growth, innovation, small cap | The world faces a shortage of electric power due to growing adoption of electric vehicles, cloud data center proliferation, and the AI revolution. Bank of America estimates these drivers will push electricity demand growth to a 2.5% annual run rate, 5x higher than the last decade's 0.5% growth. The strategic value of AI in the US-China geopolitical power struggle has made electricity production a national priority. | SOFI BE GOOGL TSLA |
View |
| 2024 Q3 | Oct 11, 2024 | Driehaus Small/Mid Cap Growth Fund | 3.1% | 24.0% | AXON, CRNX, CYBR, HEI, TMDX | AI, Biotechnology, earnings, growth, healthcare, industrials, rates, small caps | AI remains a powerful transformational theme with robust capex spending on data centers and infrastructure. Hyperscalers view AI as an existential threat to their business models and are increasing AI GPU cluster intelligence from current IQ levels of 100-120 to genius levels of 160+ and potentially 1,000. While 40% capex increases may decelerate in 2025-2026, AI infrastructure spending will remain strong. | View | |
| 2024 Q3 | Oct 11, 2024 | Driehaus Small Cap Growth Fund | 6.4% | 27.0% | AXON, CRNX, FTAI, PCVX, TMDX | AI, Biotech, growth, industrials, infrastructure, Rate Cuts, small caps | AI infrastructure spending by Hyperscalers remains robust with 40% capex increases in 2024. Manager views AI as existential threat driving continued investment in GPUs, servers, networking equipment and data centers. Expects spending to decelerate but remain strong through 2025-2026. | View | |
| 2024 Q3 | Oct 11, 2024 | Driehaus Micro Cap Growth Strategy | 8.2% | 24.0% | ADMA, ALKT, CRNX, MOD, TMDX | AI, Biotechnology, Fed Cuts, growth, healthcare, Micro Cap, small caps, valuation | AI infrastructure spending by Hyperscalers remains robust despite concerns about ROI. The manager views AI as an existential threat to major tech companies, driving continued capex investment in GPUs, servers, networking equipment and data centers. While 40% capex growth may decelerate in 2025-2026, AI infrastructure spending should remain strong. | View | |
| 2024 Q4 | Jan 3, 2025 | Rodrigo Benedetti | - | - | AAPL, AMZN, APP, CIEN, CUBI, GOOGL, META, MSFT, NVDA, PFBC, PLTR, TMDX, TSLA | AI, banks, Biotech, Europe, semiconductors, technology, value | Manager extensively analyzes AI capex spending by major tech companies, questioning sustainability of current investment levels and whether returns will justify the massive capital deployment. Notes that companies like MSFT and META are spending heavily on AI infrastructure, with some potentially approaching zero free cash flow. | View | |
| 2025 Q4 | Jan 13, 2026 | Infuse Partners | -7.2% | 0.0% | DUOL, MELI, NU, SNWV, TMDX | E-Commerce, Education, Fintech, growth, Latin America, long-term, Medical Devices, technology | MercadoLibre continues to demonstrate exceptional execution with its e-commerce/payments flywheel spinning fast even at $25 billion revenue. The company has successfully outcompeted strong marketplaces like Amazon, Shopee, Temu and TikTokShop using vertical integration and fast delivery times. Management thinks genuinely long-term unlike most companies that only give lip service to long-term decision making. Nu Holdings is gradually becoming a super app with strong traction in Mexico after receiving full banking license, proving the model is replicable outside Brazil. The company's lean cost structure enables better rates, leading to more customers and economies of scale. Success has come despite Brazil's terrible macro backdrop over 15 years, with battle-tested lending algorithms positioned for expansion into more stable geographies. Sanuwave operates a razor and blades business model with the UltraMist device for treating diabetic foot ulcers. Despite a Q3 growth hiccup while building sales organization, growth should resume as there aren't many profitable medtech companies growing faster than 30%. TransMedics has revolutionized organ transplant process, owning 22 private jets and performing 30 organ transplants daily, with increasing density creating competitive advantages. Duolingo should be viewed as an engagement machine that happens to educate rather than just a language learning app. With almost 40% of monthly users logging in daily (compared to Snapchat's 50%), the company has built exceptional engagement muscle. As it broadens into math, music, chess and other subjects, retention should increase further, potentially becoming a must-have app for learning all sorts of things. | DUOL MELI TMDX NU |
View |
| 2024 Q4 | Jan 11, 2025 | Driehaus Micro Cap Growth Strategy | 0.5% | -32.9% | CLFD, ELF, PI, TMDX, XENE | Fed policy, growth, inflation, infrastructure, Micro Cap, Onshoring, Recession, small caps | Manager believes inflation will continue to fall as key drivers like excess money supply (M2 now negative year-over-year), excess savings, and supply chain issues have largely normalized. Fed policy response to inflation trajectory remains the key market driver. | View | |
| 2024 Q3 | Sep 30, 2024 | Meridian Small Cap Growth Fund | 6.2% | 0.0% | AGS, BYRN, CARG, EVRI, LZ, MIR, MMSI, RBA, SEAT, SMAR, SRI, TMDX, TPB | Automotive, consumer, gaming, growth, healthcare, small caps | The fund holds Everi Holdings, a gaming technology company with hardware manufacturing and financial technology segments. The stock rose after a private equity acquisition offer at a 56% premium, reinforcing confidence in the financial technology segment. | TPB EVRI BYRN VICI LZ STRI |
View |
| 2024 Q3 | Sep 30, 2024 | Lord Abbett Developing Growth Fund | 6.4% | 21.1% | ADMA, CAVA, CYBR, FIX, FROG, GKOS, LOAR, PIPR, RXST, SG, TMDX, VRNS, ZETA | AI, Biotechnology, Cloud, growth, healthcare, infrastructure, small cap, technology | The fund identifies generative artificial intelligence as one of their favorite investment areas that appears ready to re-accelerate growth in 2024 and beyond. They view the emergence of generative AI as creating ample opportunities across the market cap spectrum. | View | |
| 2024 Q2 | Jul 31, 2024 | Driehaus Small Cap Growth Fund | 6.4% | 27.0% | BRBR, CAMT, CCJ, FTAI, TMDX | AI, Biotech, growth, healthcare, industrials, semiconductors, small cap, technology | The fund increased exposure to semiconductors and hardware companies tied to AI infrastructure buildout. Several holdings benefited from the hardware infrastructure buildout to support AI applications, including semi cap equipment companies and semiconductor or component suppliers to data centers. IT budgets are shifting away from enterprise software towards AI and its supporting infrastructure. | View | |
| 2024 Q2 | Jul 26, 2024 | Carillon Eagle Small Cap Growth Fund | 0.0% | 0.0% | ANF, EVH, INSM, KWR, LSCC, LSTR, MNDY, MSA, ONTO, PJT, RBA, SUM, TMDX, VEI, VKTX, WWD | AI, Biotechnology, energy, growth, healthcare, semiconductors, small caps, technology | The fund continues to see strong momentum within the AI data center buildout megatrend that is now a year old. The enormous power requirements of AI data centers have positive implications for a broader group of stocks extending across energy, industrials and utilities. The portfolio is well positioned to benefit from this theme as the surge in capital spending plans from mega-cap tech companies holds significant positive implications for several holdings within the electrical equipment and power generation industries. | View | |
| 2023 Q2 | Jul 25, 2023 | Headwaters Capital Management, LLC | 8.8% | 21.4% | ABCM, CYRX, NSIT, TMDX | - | View | ||
| 2023 Q2 | Jul 19, 2023 | Polen Capital – U.S. Small Company Growth | 7.4% | -0.9% | BE, BLDE, CRS, JOBY, ODD, ORCL, POWL, TMDX | aerospace, AI, Electrification, growth, innovation, small caps, technology | The manager views electrification as a multi-year theme driven by electric vehicles, cloud data centers, and AI revolution creating electricity demand growth of 2.5% annually versus 0.5% historically. The strategic value of AI in US-China geopolitical competition has made electricity production a national priority. | TMDX CRS ODD POWL JOBY 6BE GR |
View |
| 2024 Q2 | Jul 18, 2024 | Driehaus Micro Cap Growth Strategy | 8.2% | 24.0% | ARLO, CRNX, MOD, TMDX, TNDM | AI, growth, healthcare, industrials, inflation, Micro Cap, semiconductors, technology | The strategy increased exposure to semiconductors and hardware companies benefiting from AI infrastructure buildout. Holdings range from semi cap equipment companies to semiconductor/component suppliers to data centers. The fundamental outlook for AI-related holdings and the industry has improved dramatically. | View | |
| 2024 Q2 | Jun 30, 2024 | Meridian Growth Fund | 6.8% | 0.0% | ACVA, AGIO, ALIT, CARG, CHDN, CHWY, EEFT, RBA, RELY, SMAR, ST, STE, TMDX, TRMB, ZD | consumer discretionary, growth, healthcare, industrials, Quality, small cap, technology | The fund holds Transmedics Group, a medical technology company with a differentiated capability to facilitate organ transplants through their Organ Care System (OCS). The company reported increased adoption and buildout of its OCS platform with strong top-line growth and profitability metrics ahead of plan. | RELY TRMB ALIT AGIO CHWY TMDX |
View |
| 2024 Q2 | Jun 30, 2024 | Meridian Small Cap Growth Fund | 6.2% | 0.0% | ACVA, AGS, ALIT, BYRN, CARG, LZ, MIR, MMSI, RBA, SILK, SMAR, STNE, TMDX, TPB | downside protection, growth, Medical Devices, Quality, small caps, technology | The fund holds multiple medical technology companies including TransMedics Group with their revolutionary organ transplant technology and Silk Road Medical with their minimally invasive carotid artery treatment. These companies are taking market share with innovative solutions that improve patient outcomes. | AGS SILK TMDX ALIT BYRN LZ |
View |
| 2024 Q2 | Jun 30, 2024 | Wasatch Small Cap Growth Strategy | - | - | ADUS, BOOT, FIVE, NVMI, RPD, SITE, SPT, TMDX | AI, growth, healthcare, retail, semiconductors, small caps, technology | AI beneficiaries continued to power ahead during Q2 2024, with the strategy's best contributor being Nova Ltd., which benefited from increased inspection requirements for complex AI chips. The team has conducted extensive research on AI's potential impact across industries and owns companies that participate in AI development or benefit from related business improvements. | SPT SITE FIVE TMDX BOOT NVMI |
View |
| 2023 Q1 | Apr 19, 2023 | Polen Capital – U.S. Small Company Growth | 7.4% | -0.9% | BE, BLDE, CRS, JOBY, ODD, ORCL, POWL, TMDX | aerospace, AI, Data centers, Electrification, growth, innovation, small caps | AI data centers require enormous amounts of power, creating challenges for power grids to supply necessary electricity for constant and growing AI workloads. This has driven demand for solutions like Bloom Energy's fuel cells that can generate reliable power onsite for data centers. | TMDX CRS ODD POWL JOBY 6BE GR |
View |
| 2024 Q4 | Jan 17, 2025 | Carillon Eagle Small Cap Growth Fund | - | - | APPF, AROC, BILL, ESAB, EVH, EXR, FRSH, KWR, LPLA, LSTR, MMSI, MSA, PCVX, PI, PJT, RBA, SUM, TMDX, ZETA | AI, Election, financials, growth, healthcare, M&A, small caps, technology | The letter discusses significant AI investment themes, noting that one major chip designer's data center revenues are expected to represent approximately 15% of total U.S. capital spending in 2025. The managers highlight the risk of excess capacity if generative AI applications fail to drive demand, requiring hyperscalers to generate $400 billion in revenue to justify current spending levels. | View | |
| 2023 Q4 | Jan 17, 2024 | Driehaus Micro Cap Growth Strategy | 8.2% | 24.0% | CLFD, ELF, PI, TMDX, XENE | Fed policy, growth, inflation, infrastructure, Micro Cap, Onshoring, Recession, small caps | Manager extensively analyzes inflation drivers including excess money supply, savings, supply chains, and labor shortages. Believes inflation will continue to fall as M2 money supply turns negative, excess savings decline, and supply chains recover. Views falling inflation as key catalyst for equity market recovery. | View | |
| 2024 Q4 | Jan 14, 2025 | Headwaters Capital Management, LLC | -6.8% | 13.1% | CLMB, PLTR, TMDX | cybersecurity, Data centers, mid cap, Quality, Risk Appetite, Speculation, value | Manager emphasizes focus on quality businesses with strong fundamentals, contrasting with market rotation into speculative assets. Quality stocks significantly lagged during Q4 as investors favored high beta and non-earning companies. The strategy maintains discipline in owning quality businesses at appropriate multiples. | TMDX CLMB |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | Seeking Alpha | Seeking Alpha | TransMedics Group, Inc. | Healthcare | Medical Devices | Bear | Nasdaq Stock Market | Aircraft ownership, Free Cash Flow, international expansion, Medical devices, Organ Care System, Organ Procurement Organization, Organ Transplant, Revenue Growth, TransMedics Group, valuation | View Pitch |
| Apr 28, 2026 | Fund Letters | Polen Capital - U.S. Small Company Growth | TransMedics Group | Health Care | Health Care Equipment | Neutral | NASDAQ | healthcare innovation, Life-Saving Technology, medical technology, Organ Preservation, Organ Transplantation, Transplant Outcomes | View Pitch |
| Apr 27, 2026 | Fund Letters | Polen Capital - U.S. Small Company Growth | TransMedics Group | Health Care | Health Care Equipment | Neutral | NASDAQ | healthcare innovation, Life-Saving Technology, Medical devices, medical technology, Organ Preservation, Organ Transplant, Transplant Outcomes | View Pitch |
| Apr 13, 2026 | Fund Letters | Meridian Growth Fund | Transmedics Group, Inc. | Health Care Equipment & Services | Health Care Equipment | Bull | NASDAQ | Healthcare Equipment, market share gains, medical technology, Organ Transplant, profitability, Proprietary technology, Revenue Growth | View Pitch |
| Apr 13, 2026 | Fund Letters | Meridian Small Cap Growth Fund | TransMedics Group, Inc. | Health Care | Health Care Equipment & Supplies | Bull | NASDAQ | Healthcare Equipment, Logistics Network, Market expansion, medical technology, Organ Transplant, profitability, Proprietary technology | View Pitch |
| Apr 13, 2026 | Fund Letters | Wasatch Small Cap Growth Strategy | TransMedics Group, Inc. | Health Care | Health Care Equipment | Bull | NASDAQ | healthcare innovation, life sciences, Logistics, market share gains, medical technology, Organ Transplant | View Pitch |
| Apr 13, 2026 | Fund Letters | Headwaters Capital | TransMedics Group | Health Care | Health Care Equipment | Bull | NASDAQ | Bull, competitive moat, FDA approval, Healthcare Equipment, Logistics Network, market dominance, medical technology, Organ Transplant | View Pitch |
| Apr 13, 2026 | Fund Letters | Meridian Growth Fund | TransMedics Group, Inc. | Health Care | Health Care Equipment | Bear | NASDAQ | Bear, growth deceleration, Healthcare Equipment, Market Share Loss, medical technology, Organ Transplantation, Position Reduction | View Pitch |
| Apr 13, 2026 | Fund Letters | Meridian Small Cap Growth Fund | TransMedics Group, Inc. | Health Care | Health Care Equipment & Supplies | Bear | NASDAQ | growth deceleration, Healthcare Equipment, market share, Medical devices, medical technology, Organ Transplantation | View Pitch |
| Apr 13, 2026 | Fund Letters | Wasatch Small Cap Growth Strategy | TransMedics Group, Inc. | Health Care | Health Care Equipment | Bull | NASDAQ | Biomedical, Healthcare Equipment, life sciences, Medical devices, medical technology, Organ Transplant, Standard of Care | View Pitch |
| Feb 4, 2026 | Twitter / X | @ScorpionFund | TransMedics Group, Inc. | Health Care Equipment & Supplies | Health Care Equipment | Bear | NASDAQ | CMS, Italy, Logistics, Medtech, Perfusion, Pricing, Reimbursement, Transplant | View Pitch |
| Jan 27, 2026 | Fund Letters | Ryan Reeves | TransMedics Group, Inc. | Health Care | Medical Devices | Bull | NASDAQ | healthcare, innovation, Logistics, scale, Transplants | View Pitch |
| Jan 23, 2026 | Twitter / X | @ScorpionFund | TransMedics Group, Inc. | Health Care Services | Health Care Supplies | Bear | NASDAQ | Hiring, Linkedin, Linkedin Data, Organox, Post Says, Tmdx, Transmedics, Transplant | View Pitch |
| Sep 16, 2025 | Short Thesis | Scorpion Capital | TransMedics Group Inc | Health Care | Health Care Equipment | Bear | NASDAQ | Dilution, Organs, Reimbursement, TAM, Transplant | View Pitch |
| Aug 8, 2025 | Seeking Alpha | Fernanda Galvez Jalil | TransMedics Group, Inc. | Health Care | Medical Devices | Bull | NASDAQ | — | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||